Abstract 5478: EC-18 suppressed tumor growth and alleviated side effects caused by cisplatin in the HNSCC implantation model
Year: 2022
Type: conference-abstract
Source: Cancer Research
Institution: Enzychem Lifesciences Corporation (South Korea)
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4282924998
